Actinium to present Phase 1 data on ATNM-400 at EANM 2026

October 15, 2026 8:30 AM

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced that early results from a first-in-human Phase 1 study of its experimental cancer ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found